Atlas Pro: Revolutionizing the Way We Watch Television
In the ever-evolving world of digital...
BiPER Therapeutics Raises €800K Funding for Cancer Treatment
BiPER Therapeutics Raises €800K Funding for Cancer TreatmentBiPER Therapeutics has now secured €800k in bridge funding to help develop its novel BiP inhibitor, BPR001-615, for the treatment of gastrointestinal malignancies.
The funding raised will assist in refining BPR001-615’s pathology and regulatory preclinical study and advance toward first-in-human trials.
Please login to comment on this Post